Is this you?
Request access for Quality Research Inc with your @qualityresearch.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Quality Research Inc
Unclaimed profileIndependent Site · San Antonio, TX · ~1 sites
Intera lens
ICP 4Lift (cardio sample) 0.43Recruit soph 0.57
Quality Scorecard (1–100)
Overall83Recruit82Ops82Sponsor88Ther80
Performance (observed)
Historical trials
411
Completed
296
Terminated/Withdrawn
61
Completion rate
83%
Active now
51
Phase 2
144
Phase 3
251
Realized enrollment
863,164
First study year
1999
Years active
27
Match confidence
high
Enrollment velocity (inf)
31,969
Therapeutic
Areas
Diabetes, Cardiovascular, Gastrointestinal (IBS, GERD, H. pylori), Obesity, Osteoarthritis, Pain, Hypertension, NASH
Specialties
IBS, Diabetes, NASH, Gout, Osteoarthritis, Hypertension; Phase I-IV; 300+ completed trials
Breadth (conditions)
274
Languages
English/Spanish (on-site translator)
States
TX
Recruitment (web observed)
Meta Pixel
Yes
Trial Finder
Yes
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Y (patient-focused SEO; 29-year presence)
Capability notes
12,000-patient database; exceeds recruitment goals; extensive community outreach programs; proven track record (300+ trials, 4,000+ participants)
Relationships
Sponsors
Pfizer; AbbVie; Gilead Sciences; Eli Lilly and Company; Novo Nordisk A/S; Allergan
CROs
ICON Clinical Research; IQVIA Pty Ltd; PPD Development, LP; PPD, Part of Thermo Fisher Scientific; PRA Health Sciences; Parexel
Owner / parent
Private; founded 1996
Capacity & people
Investigators
—
Coordinators
—
CEO
Ellen Schader
VP Clinical Ops
Michelle Davis
VP Recruitment
Kay Breiner
Emails
info@qualityresearch.com; 210-822-1003
Tech & DCT
eSource
Yes
DCT / decentralized
Y (site mentions)
Recruiting visible
Y
Notes
Single site in San Antonio, 6 employees. 29-year history; 300+ trials completed; 12K-patient database. Strong recruitment but single-location limits Intera fit (needs multi-site networks). Good recruitment-focused but too small in scope. [Validated: 4 active recruiting cardiometabolic trials on ClinicalTrials.gov.]
Recommendation features (sample indication)
Ind fit 1.00Liftability 0.43Overall83
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.